Biogen Inc. (NASDAQ:BIIB) and Stoke Therapeutics, Inc. (NASDAQ:STOK) collaborated to develop and commercialize zorevunersen ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.

The partnership splits the rights to Stoke’s epilepsy antisense oligonucleotide, with up to $385 million in potential payments due to Stoke.

The planning firm that will lead Plan Baton Rouge III is Sasaki.

The context of how Kennicott’s body was discovered was also important. Strychnine poisoning can cause muscle spasms, yet Kennicott was found on top of undisturbed dirt. Had he gone into spasms, the ...

You’ll note I have yet to mention Cap — that’s because he feels like a supporting cast member in his own movie. He’s now Sam ...

4 Top Officials Say They Will Resign Over Adams’s Cooperation With Trump Four deputy mayors to Mayor Eric Adams of New York are leaving after Mr. Adams embraced President Trump’s immigration ...